European Study Demonstrates Need for Faster Diagnosis and Improved Counseling for Pulmonary Fibrosis Patients

A recent study has uncovered just how many people with pulmonary fibrosis (PF) do not receive an immediate diagnosis. This study conducted in Europe was published in Frontiers of Medicine.…

Continue Reading European Study Demonstrates Need for Faster Diagnosis and Improved Counseling for Pulmonary Fibrosis Patients

Study Finds Treatment for Pulmonary Fibrosis Effective in Later Stages of Disease

University of Illinois Researchers have uncovered novel information about pulmonary fibrosis. Their research demonstrates that fibrosis in the lungs can be reversed, and tissue can be repaired using microgel-coated mesenchymal…

Continue Reading Study Finds Treatment for Pulmonary Fibrosis Effective in Later Stages of Disease
New Potential Therapy to Treat Pulmonary Fibrosis in Systemic Sclerosis and COVID-19
source: pixabay.com

New Potential Therapy to Treat Pulmonary Fibrosis in Systemic Sclerosis and COVID-19

Pulmonary fibrosis is a condition that is caused by scarring of the lungs which can lead to shortness of breath and other respiratory issues. Some cases of COVID-19 have lead to…

Continue Reading New Potential Therapy to Treat Pulmonary Fibrosis in Systemic Sclerosis and COVID-19

Study: The Relationship Between Obesity, Lung Diseases, and Pulmonary Hypertension in Transplant Patients

The United States is coping with an obesity epidemic. It is therefore critical to understand the distribution of body fat and its effect on treatment. A recent article in Healio…

Continue Reading Study: The Relationship Between Obesity, Lung Diseases, and Pulmonary Hypertension in Transplant Patients
Presentation: Tyvaso as a Treatment for Interstitial Lung Disease
source: pixabay.com

Presentation: Tyvaso as a Treatment for Interstitial Lung Disease

United Therapeutics Corporation has recently presented data from the Phase 3 INCREASE trial, which evaluated Tyvaso as a treatment for pulmonary hypertension associated with interstitial lung disease. Results were presented…

Continue Reading Presentation: Tyvaso as a Treatment for Interstitial Lung Disease

Presentations at the ATS Conference Demonstrate the Value of the Pulmonary Fibrosis Foundation’s Patient Registry

At the 2019 American Thoracic Society Conference this year multiple presentations demonstrated the importance of the Pulmonary Fibrosis Foundation's Patient Registry. About the Registry This registry was created by the Pulmonary…

Continue Reading Presentations at the ATS Conference Demonstrate the Value of the Pulmonary Fibrosis Foundation’s Patient Registry